Licensing a Mainstay of 2013 Biotech Deal-Making
Biopharma deal-making returned to the fore during the first half of 2013, with 368 licenses and joint ventures (JV) compared to 265 during the first six months of 2012 – a 39 percent surge, according to Thomson Reuters Recap. All told, Recap captured 1,234 life science deals during the first half of the year, with licenses and JVs representing 30 percent of the total.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter